First Tracks Biotherapeutics Inc
TRAX | NASDAQ
$45.08
-$0.15 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$45.40
+$0.32 (+0.71%)
Pre-market:
Nov 2, 2026, 7:26 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|
PE Ratio | -8.42 | -13.10 | n/a | -13.97 |
PEG Ratio | 0.24 | n/a | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 4.22 | 2.56 | n/a | 1.69 |
P/FCF Ratio | -11.04 | -20.27 | n/a | -14.66 |
P/OCF Ratio | -11.04 | -20.28 | n/a | -14.67 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | n/a | 0.05 | n/a |
Quick Ratio | 14.28 | 8.74 | 10.20 | n/a |
Current Ratio | 14.28 | 8.74 | 10.20 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a |
Return on Equity | -19.77% | -19.61% | n/a | -12.05% |
Return on Assets | -18.22% | -17.37% | n/a | n/a |
Return on Invested Capital | -20.18% | -20.51% | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TRAX